These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14080944)

  • 21. Effects of laser therapy on experimental wound healing using oxidized regenerated cellulose hemostat.
    Soares LP; Oliveira MG; Pinheiro AL; Fronza BR; Maciel ME
    Photomed Laser Surg; 2008 Feb; 26(1):10-3. PubMed ID: 18248155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Oxidized Regenerated Cellulose as a Hemostatic Agent in Neurosurgery: Appraisals and Recommendations to Prevent Postoperative Complications and Facilitate Follow-Up.
    Franceschini G
    Surg Technol Int; 2021 May; 38():481-485. PubMed ID: 33592670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical benefits and risk analysis of topical hemostats: a review.
    Tomizawa Y
    J Artif Organs; 2005; 8(3):137-42. PubMed ID: 16235029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of absorbable topical hemostatic agents on the relaxation time of blood: an in vitro study with implications for postoperative magnetic resonance imaging.
    Spiller M; Tenner MS; Couldwell WT
    J Neurosurg; 2001 Oct; 95(4):687-93. PubMed ID: 11596964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of diagnosis on CT scan of Surgicel® Fibrillar: results of a prospective blind reading study.
    Frati A; Thomassin-Naggara I; Bazot M; Daraï E; Rouzier R; Chéreau E
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):397-401. PubMed ID: 23706532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of oxygenated regenerated cellulose for hemostasis in cardiac surgery].
    Belov IuV; Bazylev VV; Alekseev IA
    Khirurgiia (Mosk); 2009; (5):10-4. PubMed ID: 19491761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient procedures.
    Martyn D; Kocharian R; Lim S; Meckley LM; Miyasato G; Prifti K; Rao Y; Riebman JB; Scaife JG; Soneji Y; Corral M
    J Med Econ; 2015 Jun; 18(6):474-81. PubMed ID: 25728820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New hemostatic technique with combined use of Hydrofit
    Naganuma M; Kanda K; Sasaki K; Maeda K; Ito K; Katahira S; Saiki Y
    J Artif Organs; 2021 Sep; 24(3):358-364. PubMed ID: 33751255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgicel packing and an erroneous diagnosis of mediastinitis in a neonate.
    Alves Júnior L; Vicente WV; Ferreira CA; Manso PH; Arantes LR; Pinheiro KS; Luciano PM; Rodrigues AJ; Evora PR
    Tex Heart Inst J; 2010; 37(1):116-8. PubMed ID: 20200643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SURGICAL HEMOSTASIS AND REPAIR OF THE KIDNEY. II. EXPERIMENTAL EVALUATION OF OXIDIZED REGENERATED CELLULOSE AS A HEMOSTATIC AGENT IN EXPERIMENTAL NEPHROTOMY.
    CLARKE BG; SACHS BF; FAYER R; GHERARDI GJ
    Invest Urol; 1963 Jul; 1():31-44. PubMed ID: 14076305
    [No Abstract]   [Full Text] [Related]  

  • 31. [ON THE USE OF SURGICEL IN NEUROSURGERY].
    ZOLTAN L
    Minerva Neurochir; 1964; 83():41-3. PubMed ID: 14164605
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgicel mimicking recurrent pelvic neuroblastoma in a 3-year-old boy.
    Turkyilmaz Z; Karabulut R; Kaya C; Gökce D; Kolay E; Sonmez K
    Acta Chir Belg; 2022 Aug; 122(4):266-268. PubMed ID: 33534658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxycel, a new hemostatic agent.
    MAETH H
    Dent Dig; 1946 Dec; 52(12):669-72. PubMed ID: 20279720
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding.
    Uranues S; Fingerhut A; Levin E; Spazierer D; Rahimi N; Baumgartner B
    BMC Surg; 2022 Aug; 22(1):316. PubMed ID: 35965336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of oxidized regenerated cellulose as a hemostatic agent in dogs.
    MILLER JM; THOMAS VT
    Exp Med Surg; 1961; 19():192-5. PubMed ID: 14474050
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
    Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of self-prepared absorbable hemostatic cellulose fibrils.
    Wang L; Tong J; Zhao Z; Yang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):633-641. PubMed ID: 34986534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical stenosis of pulmonary homograft induced by Surgicel in Ross procedure.
    Teis A; Cámara ML; Ferrer E; Romero-Ferrer B
    Asian Cardiovasc Thorac Ann; 2010 Aug; 18(4):382-3. PubMed ID: 20719793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of oxidized cellulose and microfibrillar collagen on infection.
    Scher KS; Coil JA
    Surgery; 1982 Mar; 91(3):301-4. PubMed ID: 7058512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro evaluation of antimicrobial activity of absorbable topical hemostatic agents used in the operating room].
    Piana A; Mura I; Deidda S; Lo Curto P; Are BM; Maida G; Masia MD
    Ig Sanita Pubbl; 2013; 69(6):611-8. PubMed ID: 24548902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.